Advertisement
Screener

89bio, Inc. Cash and Cash Equivalents

89bio, Inc. Cash and Cash Equivalents

89bio, Inc. had Cash and Cash Equivalents of $129.08 million as of 2025-06-30, per its 10-Q filed 2025-08-08.

Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments

us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2025-08-08

  • 2025-06-30: Cash and Cash Equivalents, at Carrying Value $129.08M.
  • 2025-03-31: Cash and Cash Equivalents, at Carrying Value $315.40M.
  • 2024-12-31: Cash and Cash Equivalents, at Carrying Value $126.06M.
  • 2024-09-30: Cash and Cash Equivalents, at Carrying Value $91.41M.
Period endCash and Cash Equivalents, at Carrying Value
2025-06-30$129.08M
10-Q · filed 2025-08-08
2025-03-31$315.40M
10-Q · filed 2025-05-02
2024-12-31$126.06M
10-Q · filed 2025-08-08
2024-09-30$91.41M
10-Q · filed 2024-11-07
2024-06-30$212.22M
10-Q · filed 2024-08-05
2024-03-31$217.57M
10-Q · filed 2024-05-09
2023-12-31$316.16M
10-K · filed 2025-02-27
2023-09-30$251.93M
10-Q · filed 2023-11-09
2023-06-30$245.44M
10-Q · filed 2023-08-09
2023-03-31$350.93M
10-Q · filed 2023-05-08
2022-12-31$55.26M
10-K · filed 2024-03-01
2022-09-30$72.40M
10-Q · filed 2022-11-10
2022-06-30$60.62M
10-Q · filed 2023-08-09
2022-03-31$54.89M
10-Q · filed 2023-05-08
2021-12-31$52.43M
10-K · filed 2024-03-01
2021-09-30$39.70M
10-Q · filed 2022-11-10
2021-06-30$35.71M
10-Q · filed 2022-08-11
2021-03-31$68.01M
10-Q · filed 2022-05-12
2020-12-31$98.18M
10-K · filed 2022-03-24
2020-09-30$141.55M
10-Q · filed 2021-11-12
2020-06-30$68.20M
10-Q · filed 2021-08-13
2020-03-31$85.53M
10-Q · filed 2021-05-14
2019-12-31$93.33M
10-K · filed 2021-03-25
2019-09-30$16.19M
10-Q · filed 2020-11-13
2019-06-30$21.92M
10-Q · filed 2020-08-13
2019-03-31$7.06M
10-Q · filed 2020-05-13
2018-12-31$11.23M
10-K · filed 2020-03-18
2018-09-30$5.53M
10-Q · filed 2019-12-18